Synta Pharmaceuticals Company
Synta Pharmaceuticals is focused on developing and commercializing small molecule drugs to treat cancer and chronic inflammatory diseases.
Technology:
Others
Industry:
PharmTech
Headquarters:
Lexington, Massachusetts, United States
Founded Date:
2000-01-01
Employees Number:
51-100
Funding Status:
IPO
Total Funding:
217350000
Estimated Revenue:
$10M to $50M
Last Funding Type:
Post-IPO Equity
Register and Claim Ownership